Regulatory Affairs Professionals Society

MedCon: FDA, industry experts discuss best practices for managing software defects, anomalies

The difference between an anomaly and a defect in product software can be confusing, but it is important to identify which is ...
RAPS

Investment in quality management can reduce defects and recalls, FDA says

Companies that invest in quality management initiatives can incur lower costs related to defects, waste, and recalls compared to those that do not make such investments, according to a white paper ...